BiomX Inc. (PHGE)
AMEX: PHGE
· Real-Time Price · USD
0.53
-0.03 (-5.02%)
At close: Aug 18, 2025, 3:59 PM
0.52
-1.52%
Pre-market: Aug 19, 2025, 05:18 AM EDT
-5.02% (1D)
| Bid | 0.5 |
| Market Cap | 13.79M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.02 |
| PE Ratio (ttm) | -26.35 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 0.56 |
| Volume | 558,851 |
| Avg. Volume (20D) | 5,079,991 |
| Open | 0.54 |
| Previous Close | 0.56 |
| Day's Range | 0.51 - 0.55 |
| 52-Week Range | 0.34 - 1.70 |
| Beta | 1.43 |
About PHGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PHGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PHGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+3.37%
PHGE stock has given up its prior gain. BiomX shar...
Unlock content with
Pro Subscription
1 month ago
+3.37%
BiomX shares are trading higher after the company announced the initiation of its Phase 2b trial with the first patient dosed in its BX004 program for the treatment of cystic fibrosis.
